Copanlisib in Combination with Nivolumab in Subjects with Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma: A Phase II Study

被引：0

作者：

Bennani, N. Nora ^{[1
]}

Atherton, Pamela ^{[1
]}

Steinert, Kimberly O. ^{[1
]}

Rimsza, Lisa M. ^{[2
]}

Tun, Aung M. ^{[3
]}

Hoffmann, Marc S. ^{[4
]}

Narkhede, Mayur S. ^{[5
]}

Vaidya, Rakhee ^{[6
]}

Said, Rabih ^{[7
]}

Shapiro, Geoffrey I. ^{[8
]}

Costello, Brian A. ^{[9
]}

Ansell, Stephen M. ^{[10
]}

Nowakowski, Grzegorz S. ^{[10
]}

机构：

[1] Mayo Clin, Rochester, MN USA

[2] Mayo Clin, Dept Lab Med & Pathol, Phoenix, AZ USA

[3] Univ Kansas, Div Hematol Malignancies & Cellular Therapeut, Westwood, KS USA

[4] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA

[5] Univ Alabama Birmingham, Dept Hematol Oncol, Birmingham, AL USA

[6] Wake Forest, Winston Salem, NC USA

[7] NCI, Invest Drug Branch, CTEP, Rockville, MD USA

[8] Dana Farber Canc Inst, Boston, MA 02115 USA

[9] Mayo Clin, Med Oncol, Rochester, MN USA

[10] Mayo Clin, Div Hematol, Rochester, MN USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-190540

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[21] Primary Mediastinal Large B-cell Lymphoma [J].

Anna Dabrowska-Iwanicka ;

Jan A. Walewski .

Current Hematologic Malignancy Reports, 2014, 9 :273-283

[22] Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma [J].

Schuster, Stephen J. ;

Bishop, Michael R. ;

Tam, Constantine S. ;

Waller, Edmund K. ;

Borchmann, Peter ;

McGuirk, Joseph P. ;

Jaeger, Ulrich ;

Jaglowski, Samantha ;

Andreadis, Charalambos ;

Westin, Jason R. ;

Fleury, Isabelle ;

Bachanova, Veronika ;

Foley, S. Ronan ;

Ho, P. Joy p ;

Mielke, Stephan ;

Magenau, John M. ;

Holte, Harald ;

Pantano, Serafino ;

Pacaud, Lida B. ;

Awasthi, Rakesh ;

Chu, Jufen ;

Anak, Ozlem ;

Salles, Gilles ;

Maziarz, Richard T. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (01) :45-56

[23] Polatuzumab vedotin in relapsed/refractory diffuse large B-cell lymphoma [J].

Dietliker, N. ;

Kiesel, H. ;

Mueller, R. ;

Mueller, A. M. ;

Manz, M. G. ;

Zenz, T. ;

Rosler, W. .

SWISS MEDICAL WEEKLY, 2020, :21S-21S

[24] Novel agents in relapsed/refractory diffuse large B-cell lymphoma [J].

Varma, Gaurav ;

Goldstein, Jordan ;

Advani, Ranjana H. .

HEMATOLOGICAL ONCOLOGY, 2023, 41 :92-106

[25] Polatuzumab vedotin in relapsed/refractory diffuse large B-cell lymphoma [J].

Dietliker, N. ;

Kiesel, H. ;

Mueller, R. ;

Mueller, A. M. ;

Manz, M. ;

Zenz, T. ;

Rosler, W. .

ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) :66-67

[26] Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma [J].

Sehn, Laurie H. ;

Herrera, Alex F. ;

Flowers, Christopher R. ;

Kamdar, Manali K. ;

McMillan, Andrew ;

Hertzberg, Mark ;

Assouline, Sarit ;

Kim, Tae Min ;

Kim, Won Seog ;

Ozcan, Muhit ;

Hirata, Jamie ;

Penuel, Elicia ;

Paulson, Joseph N. ;

Cheng, Ji ;

Ku, Grace ;

Matasar, Matthew J. .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (02) :155-+

[27] Tafasitamab for the treatment of relapsed or refractory diffuse large B-cell lymphoma [J].

Salles, Gilles ;

Dlugosz-Danecka, Monika ;

Ghesquieres, Herve ;

Jurczak, Wojciech .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (04) :455-463

[28] Novel Therapies for Relapsed or Refractory Diffuse Large B-Cell Lymphoma [J].

Harris, Leonard Jeff ;

Patel, Kruti ;

Martin, Michael .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22)

[29] Relapsed or Refractory Diffuse Large B-Cell Lymphoma: "Dazed and Confused" [J].

Kesireddy, Meghana ;

Lunning, Matthew A. .

ONCOLOGY-NEW YORK, 2022, 36 (06) :360-369

[30] Phylogenetic Evolution in Refractory/Relapsed Diffuse Large B-Cell Lymphoma [J].

Ruminy, Philippe ;

Rainville, Vinciane ;

Mareschal, Sylvain ;

Etancelin, Pascaline ;

Joly, Berangere ;

Picquenot, Jean-Michel ;

Bastard, Christian ;

Tilly, Herve ;

Jardin, Fabrice .

BLOOD, 2012, 120 (21)

← 1 2 3 4 5 →